United States

Cambrex Corp (CBM.N)

CBM.N on New York Stock Exchange

24 Feb 2017
Change (% chg)

$0.30 (+0.54%)
Prev Close
Day's High
Day's Low
Avg. Vol
52-wk High
52-wk Low


Chart for CBM.N


Cambrex Corporation (Cambrex) is a life sciences company. It provides products and services for the development and commercialization of generic therapeutics. It operates through four segments, which are manufacturing facilities that have been aggregated as a single segment. Its manufacturing facilities are owned by the... (more)


Beta: 2.07
Market Cap(Mil.): $1,808.18
Shares Outstanding(Mil.): 32.35
Dividend: --
Yield (%): --


  CBM.N Industry Sector
P/E (TTM): 21.11 28.84 29.63
EPS (TTM): 2.65 -- --
ROI: 19.58 13.44 12.96
ROE: 24.38 14.34 14.11

BRIEF-Cambrex reports Q3 GAAP earnings per share $0.42 from continuing operations

* Says company expects full year 2016 sales, excluding impact of foreign currency, to increase between 12% and 14% compared to 2015.

Nov 04 2016

BRIEF-Cambrex Corp appoints Bernhard Hampl to the board of directors

* Bernhard Hampl appointed to the board of directors of Cambrex Corporation Source text for Eikon: Further company coverage:

Oct 31 2016

BRIEF-Cambrex to acquire Pharmacore to expand clinical stage API capabilities

* Cambrex to acquire Pharmacore Inc to expand clinical stage API capabilities

Sep 26 2016

More From Around the Web

Earnings vs. Estimates